Several possible studies
Story checked
Nasal spray brings pain relief for children treated in the emergency department (opens in a new tab)
medicalxpress.com · 2026-09-27
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Nasal spray brings pain relief for children treated in the emergency department
medicalxpress.com · 2026-09-27
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 7Not checkedA pain treatment delivered by nasal spray offers an effective, needle-free option for children being seen in emergency departments for a range of injuries.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 7Not checkedThe research was presented at the European Emergency Medicine Congress by Shammi Ramlakhan, an emergency medicine consultant working at Sheffield Children's Hospital, the University of Sheffield and Sheffield Hallam University in the UK.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 7Not checkedThe study included 152 children ages 1 to 17 with moderate to severe pain who were treated at seven emergency departments in the UK and Spain between May 2024 and May 2025.View evidenceHide evidence
As stated152 children ages 1 to 17; seven emergency departments; May 2024 to May 2025
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 7Not checkedAll children were given sufentanil and ketamine via a nasal spray, with the dose adjusted by weight using a variable number of puffs.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 7Not checkedAfter 15 minutes, 54% of the children were in less pain, and after 30 minutes, 88% were in less pain; pain was reduced by around half in 86.2% of children at 30 minutes.View evidenceHide evidence
As stated54% at 15 minutes; 88% at 30 minutes; 86.2% had pain reduced by around half at 30 minutes
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 7Not checkedSide effects were described as mild and included nausea or vomiting, dizziness and nasal itching, with no major side effects reported.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 7 of 7Not checkedResearchers said the treatment was being tested for the European Medicines Agency's pediatric-use marketing authorization scheme and could be available for use in Europe in the near future.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
Intranasal sufentanil versus ketamine for acute severe traumatic pain in children: protocol for a phase II randomised controlled trial (SUF-KET-PED).
BMJ Open · 2026 · PubMed, Europe PMC
The Effectiveness of Intranasal Ketamine on Intramuscular Ketamine Injection Pain Among Children in the Emergency Department, a Randomized, Controlled Trial
Pediatric Emergency Care · 2025 · Crossref
Intranasal dexmedetomidine versus midazolam for pediatric dental sedation: a pooled analysis of clinical trials.
2026 · Europe PMC
The Influence of Pharmacological Agents Used During General Anesthesia on the Intensity of Postoperative Pain and the Occurrence of Post-Anesthetic Delirium-A Scoping Review.
Journal of Clinical Medicine · 2026 · PubMed, Europe PMC
Intranasal sufentanil compared with a classic protocol for acute pain management in an emergency department: A prospective sequential study
Trauma · 2023 · Crossref
And 10 more candidates considered.